For the Zantac lawsuit payouts, plaintiffs will fall into one of three tiers: Tier 1 injuries can expect payouts in the $300,000 range. Injuries in this tier include cancers of the stomach ...

Zantac’s manufacturers were on a roll. Their defense had exacted a spate of favorable decisions and jury verdicts. Yet, on October 9, Glaxo Smith Kline (GSK) suddenly settled 93% of the remaining ...

Revenue dipped 1.7 percent to £8 billion in the reporting period, a statement added. GSK earlier this month agreed to pay $2.3 billion to end lawsuits alleging that Zantac caused cancer ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

“There are 16 epidemiological studies looking at human data regarding the use of ranitidine, including outcomes for more than 1 million patients using ranitidine, supporting this consensus.

Operating profit fell by 86 per cent, and earnings per share slumped due to a settlement charge of £1.8bn related to the ...

Meanwhile, revenue for the three-month period fell 1.7% to GBP8.01 billion from ... "We also resolved the vast majority of Zantac litigation in the quarter, to remove uncertainty, and so we ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

The 15.9 lb Orange Crush 20RT comes fully equipped with an 8-inch, custom-designed ‘Voice Of The World’ speaker, a 3-band EQ, ...

GSK’s $2.2 billion Zantac settlement today put its shares top ... although Hiscox and Beazley both rose 1.5% today after the storm was downgraded to category one as it passed off the Florida ...

AMP) share price is surging higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) financial services company closed yesterday trading for $1.355. In morning trade on Thursday, shares are ...